デフォルト表紙
市場調査レポート
商品コード
1654746

キノロン系抗菌薬中間体市場 - 世界市場シェア、ランキング、全体売上高、需要予測 2025-2031

Quinolone Antibacterial Drug Intermediates - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

出版日
発行
QYResearch
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.26円
キノロン系抗菌薬中間体市場 - 世界市場シェア、ランキング、全体売上高、需要予測 2025-2031
出版日: 2025年02月14日
発行: QYResearch
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

当レポートは、キノロン系抗菌薬中間体 (Quinolone Antibacterial Drug Intermediates) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • キノロン系抗菌薬中間体の製品概要
  • 世界のキノロン系抗菌薬中間体 市場規模 予測
    • 世界のキノロン系抗菌薬中間体 売上 価格 (2020-2031)
    • Global Quinolone Antibacterial Drug Intermediates Sales Volume (2020-2031)
    • Global Quinolone Antibacterial Drug Intermediates Sales Price (2020-2031)
  • キノロン系抗菌薬中間体 市場トレンド & ドライバ
    • キノロン系抗菌薬中間体 業界動向
    • Quinolone Antibacterial Drug Intermediates Market Drivers & Opportunity
    • Quinolone Antibacterial Drug Intermediates Market Challenges
    • Quinolone Antibacterial Drug Intermediates Market Restraints
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 競合分析 企業別

  • 世界のキノロン系抗菌薬中間体 企業別収益ランキング (2024)
  • 世界のキノロン系抗菌薬中間体 企業別収益 (2020-2025)
  • 世界のキノロン系抗菌薬中間体 企業別販売数量ランキング (2024)
  • 世界のキノロン系抗菌薬中間体 企業別販売数量 (2020-2025)
  • 世界のキノロン系抗菌薬中間体 企業別平均価格 (2020-2025)
  • 主要企業 キノロン系抗菌薬中間体 製造拠点、本社
  • 主要企業 キノロン系抗菌薬中間体 取扱商品
  • 主要メーカーの量産開始時期 キノロン系抗菌薬中間体
  • キノロン系抗菌薬中間体 市場 競合分析
    • キノロン系抗菌薬中間体の市場：濃度別 (2020-2025)
    • 世界の5大・10大企業 キノロン系抗菌薬中間体の収益 2024
    • 世界の企業 企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース キノロン系抗菌薬中間体 2024年)
  • M&A、事業拡大

第3章 セグメンテーション タイプ別

  • 概要 タイプ別
    • Levofloxacin Carboxylic Acid
    • Fluoroquinolonic Acid
    • Tetrafluorophthalic Acid
    • Others
  • 世界のキノロン系抗菌薬中間体 売上 価格 タイプ別
    • 世界のキノロン系抗菌薬中間体 売上 価格 タイプ別 (2020 VS 2024 VS 2031)
    • 世界のキノロン系抗菌薬中間体 売上 価格, タイプ別 (2020-2031)
    • 世界のキノロン系抗菌薬中間体 売上 価格, タイプ別 (%) (2020-2031)
  • 世界のキノロン系抗菌薬中間体 販売数量 タイプ別
    • 世界のキノロン系抗菌薬中間体 販売数量 タイプ別 (2020 VS 2024 VS 2031)
    • 世界のキノロン系抗菌薬中間体 販売数量 タイプ別 (2020-2031)
    • 世界のキノロン系抗菌薬中間体 販売数量 タイプ別 (%) (2020-2031)
  • 世界のキノロン系抗菌薬中間体 平均価格 タイプ別 (2020-2031)

第4章 セグメンテーション 用途別

  • 概要 用途別
    • Ofloxacin
    • Moxifloxacin
    • Ciprofloxacin
    • Others
  • 世界のキノロン系抗菌薬中間体 売上 価格 用途別
    • 世界のキノロン系抗菌薬中間体 売上 価格 用途別 (2020 VS 2024 VS 2031)
    • 世界のキノロン系抗菌薬中間体 売上 価格, 用途別 (2020-2031)
    • 世界のキノロン系抗菌薬中間体 売上 価格, 用途別 (%) (2020-2031)
  • 世界のキノロン系抗菌薬中間体 販売数量 用途別
    • 世界のキノロン系抗菌薬中間体 販売数量 用途別 (2020 VS 2024 VS 2031)
    • 世界のキノロン系抗菌薬中間体 販売数量 用途別 (2020-2031)
    • 世界のキノロン系抗菌薬中間体 販売数量 用途別 (%) (2020-2031)
  • 世界のキノロン系抗菌薬中間体 平均価格 用途別 (2020-2031)

第5章 セグメンテーション 地域別

  • 世界のキノロン系抗菌薬中間体 売上 価格 地域別
    • 世界のキノロン系抗菌薬中間体 売上 価格 地域別: 2020 VS 2024 VS 2031
    • 世界のキノロン系抗菌薬中間体 売上 価格 地域別 (2020-2025)
    • 世界のキノロン系抗菌薬中間体 売上 価格 地域別 (2026-2031)
    • 世界のキノロン系抗菌薬中間体 売上 価格 地域別 (%), (2020-2031)
  • 世界のキノロン系抗菌薬中間体 販売数量 地域別
    • 世界のキノロン系抗菌薬中間体 販売数量 地域別: 2020 VS 2024 VS 2031
    • 世界のキノロン系抗菌薬中間体 販売数量 地域別 (2020-2025)
    • 世界のキノロン系抗菌薬中間体 販売数量 地域別 (2026-2031)
    • 世界のキノロン系抗菌薬中間体 販売数量 地域別 (%), (2020-2031)
  • 世界のキノロン系抗菌薬中間体 平均価格 地域別 (2020-2031)
  • 北米
    • 北米のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 北米のキノロン系抗菌薬中間体 売上 価格 国別 (%), 2024 VS 2031
  • 欧州
    • 欧州のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 欧州のキノロン系抗菌薬中間体 売上 価格 国別 (%), 2024 VS 2031
  • アジア太平洋
    • アジア太平洋のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • アジア太平洋のキノロン系抗菌薬中間体 売上 価格 地域別 (%), 2024 VS 2031
  • 南アメリカ
    • 南アメリカ キノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 南アメリカ キノロン系抗菌薬中間体 売上 価格 国別 (%), 2024 VS 2031
  • 中東・アフリカ
    • 中東・アフリカのキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 中東・アフリカのキノロン系抗菌薬中間体 売上 価格 国別 (%), 2024 VS 2031

第6章 セグメンテーション 主要国・地域別

  • 主要国・地域のキノロン系抗菌薬中間体 売上高成長トレンド, 2020 VS 2024 VS 2031
  • 主要国・地域のキノロン系抗菌薬中間体 売上 価格 and 販売数量
    • 主要国・地域のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 主要国・地域のキノロン系抗菌薬中間体 販売数量, 2020-2031
  • 米国
    • 米国 キノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 米国 キノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 米国 キノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • 欧州
    • 欧州のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 欧州のキノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 欧州のキノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • 中国
    • 中国のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 中国のキノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 中国のキノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • 日本
    • 日本のキノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 日本のキノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 日本のキノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • 韓国
    • 韓国 キノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 韓国 キノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 韓国 キノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • 東南アジア
    • 東南アジア キノロン系抗菌薬中間体 売上 価格, 2020-2031
    • 東南アジア キノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • 東南アジア キノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031
  • インド
    • インド キノロン系抗菌薬中間体 売上 価格, 2020-2031
    • インド キノロン系抗菌薬中間体 売上 価格 タイプ別 (%), 2024 VS 2031
    • インド キノロン系抗菌薬中間体 売上 価格 用途別, 2024 VS 2031

第7章 企業プロファイル

  • Anant Pharmaceuticals
  • Veeprho Pharmaceuticals
  • Anax Laboratories
  • Santa Cruz Biotechnology
  • Chemicea Pharmaceuticals
  • Zhejiang Starry Pharmaceutical
  • Jiangxi Chibang Pharmaceutical
  • Inner Mongania Yuanhong Fine Chemical
  • Jiangxi Chenyang Pharmaceutical
  • Jiangxi Dadi Pharm
  • Shanghai Nuvit Bio-Tech
  • Biocompounds Pharmaceutical
  • Guobang Pharma
  • Binhai Golden Hilen
  • Zhejiang Langhua Pharmaceutical
  • Zhejiang Jingxin Pharmaceutical

第8章 業界チェーン分析

  • キノロン系抗菌薬中間体 産業チェーン
  • キノロン系抗菌薬中間体 上流分析
    • 主要原材料
    • 原材料の主要サプライヤー
    • 製造コスト構造
  • 中流分析
  • 下流分析 (顧客分析)
  • 販売モデルと販売チャネル
    • キノロン系抗菌薬中間体 販売モデル
    • 販売チャネル
    • キノロン系抗菌薬中間体 卸業者

第9章 市場調査結果と結論

第10章 付録

図表

List of Tables

Table 1. Quinolone Antibacterial Drug Intermediates Market Trends

Table 2. Quinolone Antibacterial Drug Intermediates Market Drivers & Opportunity

Table 3. Quinolone Antibacterial Drug Intermediates Market Challenges

Table 4. Quinolone Antibacterial Drug Intermediates Market Restraints

Table 5. Global Quinolone Antibacterial Drug Intermediates Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Quinolone Antibacterial Drug Intermediates Revenue Market Share by Company (2020-2025)

Table 7. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Quinolone Antibacterial Drug Intermediates Price by Company (2020-2025) & (US$/Ton)

Table 10. Key Manufacturers Quinolone Antibacterial Drug Intermediates Manufacturing Base and Headquarters

Table 11. Key Manufacturers Quinolone Antibacterial Drug Intermediates Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Quinolone Antibacterial Drug Intermediates

Table 13. Global Quinolone Antibacterial Drug Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quinolone Antibacterial Drug Intermediates as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Quinolone Antibacterial Drug Intermediates Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Quinolone Antibacterial Drug Intermediates Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Quinolone Antibacterial Drug Intermediates Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Quinolone Antibacterial Drug Intermediates Sales Market Share in Value by Type (2020-2025)

Table 20. Global Quinolone Antibacterial Drug Intermediates Sales Market Share in Value by Type (2026-2031)

Table 21. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Type (2020-2025)

Table 25. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Type (2026-2031)

Table 26. Global Quinolone Antibacterial Drug Intermediates Price by Type (2020-2025) & (US$/Ton)

Table 27. Global Quinolone Antibacterial Drug Intermediates Price by Type (2026-2031) & (US$/Ton)

Table 28. Global Quinolone Antibacterial Drug Intermediates Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Quinolone Antibacterial Drug Intermediates Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Quinolone Antibacterial Drug Intermediates Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Quinolone Antibacterial Drug Intermediates Sales Market Share in Value by Application (2020-2025)

Table 32. Global Quinolone Antibacterial Drug Intermediates Sales Market Share in Value by Application (2026-2031)

Table 33. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Application (2020-2025)

Table 37. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Application (2026-2031)

Table 38. Global Quinolone Antibacterial Drug Intermediates Price by Application (2020-2025) & (US$/Ton)

Table 39. Global Quinolone Antibacterial Drug Intermediates Price by Application (2026-2031) & (US$/Ton)

Table 40. Global Quinolone Antibacterial Drug Intermediates Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2020-2025) & (%)

Table 44. Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2026-2031) & (%)

Table 45. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2020-2025) & (%)

Table 49. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2026-2031) & (%)

Table 50. Global Quinolone Antibacterial Drug Intermediates Average Price by Region (2020-2025) & (US$/Ton)

Table 51. Global Quinolone Antibacterial Drug Intermediates Average Price by Region (2026-2031) & (US$/Ton)

Table 52. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Volume, (2026-2031) & (Tons)

Table 57. Anant Pharmaceuticals Company Information

Table 58. Anant Pharmaceuticals Introduction and Business Overview

Table 59. Anant Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 60. Anant Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings

Table 61. Anant Pharmaceuticals Recent Development

Table 62. Veeprho Pharmaceuticals Company Information

Table 63. Veeprho Pharmaceuticals Introduction and Business Overview

Table 64. Veeprho Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 65. Veeprho Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings

Table 66. Veeprho Pharmaceuticals Recent Development

Table 67. Anax Laboratories Company Information

Table 68. Anax Laboratories Introduction and Business Overview

Table 69. Anax Laboratories Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 70. Anax Laboratories Quinolone Antibacterial Drug Intermediates Product Offerings

Table 71. Anax Laboratories Recent Development

Table 72. Santa Cruz Biotechnology Company Information

Table 73. Santa Cruz Biotechnology Introduction and Business Overview

Table 74. Santa Cruz Biotechnology Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Santa Cruz Biotechnology Quinolone Antibacterial Drug Intermediates Product Offerings

Table 76. Santa Cruz Biotechnology Recent Development

Table 77. Chemicea Pharmaceuticals Company Information

Table 78. Chemicea Pharmaceuticals Introduction and Business Overview

Table 79. Chemicea Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 80. Chemicea Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings

Table 81. Chemicea Pharmaceuticals Recent Development

Table 82. Zhejiang Starry Pharmaceutical Company Information

Table 83. Zhejiang Starry Pharmaceutical Introduction and Business Overview

Table 84. Zhejiang Starry Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 85. Zhejiang Starry Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 86. Zhejiang Starry Pharmaceutical Recent Development

Table 87. Jiangxi Chibang Pharmaceutical Company Information

Table 88. Jiangxi Chibang Pharmaceutical Introduction and Business Overview

Table 89. Jiangxi Chibang Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 90. Jiangxi Chibang Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 91. Jiangxi Chibang Pharmaceutical Recent Development

Table 92. Inner Mongania Yuanhong Fine Chemical Company Information

Table 93. Inner Mongania Yuanhong Fine Chemical Introduction and Business Overview

Table 94. Inner Mongania Yuanhong Fine Chemical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 95. Inner Mongania Yuanhong Fine Chemical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 96. Inner Mongania Yuanhong Fine Chemical Recent Development

Table 97. Jiangxi Chenyang Pharmaceutical Company Information

Table 98. Jiangxi Chenyang Pharmaceutical Introduction and Business Overview

Table 99. Jiangxi Chenyang Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 100. Jiangxi Chenyang Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 101. Jiangxi Chenyang Pharmaceutical Recent Development

Table 102. Jiangxi Dadi Pharm Company Information

Table 103. Jiangxi Dadi Pharm Introduction and Business Overview

Table 104. Jiangxi Dadi Pharm Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 105. Jiangxi Dadi Pharm Quinolone Antibacterial Drug Intermediates Product Offerings

Table 106. Jiangxi Dadi Pharm Recent Development

Table 107. Shanghai Nuvit Bio-Tech Company Information

Table 108. Shanghai Nuvit Bio-Tech Introduction and Business Overview

Table 109. Shanghai Nuvit Bio-Tech Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 110. Shanghai Nuvit Bio-Tech Quinolone Antibacterial Drug Intermediates Product Offerings

Table 111. Shanghai Nuvit Bio-Tech Recent Development

Table 112. Biocompounds Pharmaceutical Company Information

Table 113. Biocompounds Pharmaceutical Introduction and Business Overview

Table 114. Biocompounds Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 115. Biocompounds Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 116. Biocompounds Pharmaceutical Recent Development

Table 117. Guobang Pharma Company Information

Table 118. Guobang Pharma Introduction and Business Overview

Table 119. Guobang Pharma Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 120. Guobang Pharma Quinolone Antibacterial Drug Intermediates Product Offerings

Table 121. Guobang Pharma Recent Development

Table 122. Binhai Golden Hilen Company Information

Table 123. Binhai Golden Hilen Introduction and Business Overview

Table 124. Binhai Golden Hilen Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 125. Binhai Golden Hilen Quinolone Antibacterial Drug Intermediates Product Offerings

Table 126. Binhai Golden Hilen Recent Development

Table 127. Zhejiang Langhua Pharmaceutical Company Information

Table 128. Zhejiang Langhua Pharmaceutical Introduction and Business Overview

Table 129. Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 130. Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 131. Zhejiang Langhua Pharmaceutical Recent Development

Table 132. Zhejiang Jingxin Pharmaceutical Company Information

Table 133. Zhejiang Jingxin Pharmaceutical Introduction and Business Overview

Table 134. Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 135. Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings

Table 136. Zhejiang Jingxin Pharmaceutical Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Quinolone Antibacterial Drug Intermediates Downstream Customers

Table 140. Quinolone Antibacterial Drug Intermediates Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Quinolone Antibacterial Drug Intermediates Product Picture

Figure 2. Global Quinolone Antibacterial Drug Intermediates Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Quinolone Antibacterial Drug Intermediates Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Quinolone Antibacterial Drug Intermediates Sales Volume (2020-2031) & (Tons)

Figure 5. Global Quinolone Antibacterial Drug Intermediates Sales Price (2020-2031) & (US$/Ton)

Figure 6. Quinolone Antibacterial Drug Intermediates Report Years Considered

Figure 7. Global Quinolone Antibacterial Drug Intermediates Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Quinolone Antibacterial Drug Intermediates Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Quinolone Antibacterial Drug Intermediates Revenue in 2024

Figure 10. Quinolone Antibacterial Drug Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Levofloxacin Carboxylic Acid Picture

Figure 12. Fluoroquinolonic Acid Picture

Figure 13. Tetrafluorophthalic Acid Picture

Figure 14. Others Picture

Figure 15. Global Quinolone Antibacterial Drug Intermediates Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Quinolone Antibacterial Drug Intermediates Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 18. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Quinolone Antibacterial Drug Intermediates Price by Type (2020-2031) & (US$/Ton)

Figure 20. Product Picture of Ofloxacin

Figure 21. Product Picture of Moxifloxacin

Figure 22. Product Picture of Ciprofloxacin

Figure 23. Product Picture of Others

Figure 24. Global Quinolone Antibacterial Drug Intermediates Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 25. Global Quinolone Antibacterial Drug Intermediates Sales Value Market Share by Application, 2024 & 2031

Figure 26. Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 27. Global Quinolone Antibacterial Drug Intermediates Sales Volume Market Share by Application, 2024 & 2031

Figure 28. Global Quinolone Antibacterial Drug Intermediates Price by Application (2020-2031) & (US$/Ton)

Figure 29. North America Quinolone Antibacterial Drug Intermediates Sales Value (2020-2031) & (US$ Million)

Figure 30. North America Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031

Figure 31. Europe Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031

Figure 33. Asia Pacific Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Quinolone Antibacterial Drug Intermediates Sales Value by Region (%), 2024 VS 2031

Figure 35. South America Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 36. South America Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031

Figure 37. Middle East & Africa Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 38. Middle East & Africa Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031

Figure 39. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value (%), (2020-2031)

Figure 40. Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Volume (%), (2020-2031)

Figure 41. United States Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 42. United States Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 43. United States Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 44. Europe Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 45. Europe Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 46. Europe Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 47. China Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 48. China Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 49. China Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 50. Japan Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 51. Japan Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 52. Japan Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 53. South Korea Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 54. South Korea Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 55. South Korea Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 56. Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 57. Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 58. Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 59. India Quinolone Antibacterial Drug Intermediates Sales Value, (2020-2031) & (US$ Million)

Figure 60. India Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031

Figure 61. India Quinolone Antibacterial Drug Intermediates Sales Value by Application (%), 2024 VS 2031

Figure 62. Quinolone Antibacterial Drug Intermediates Industrial Chain

Figure 63. Quinolone Antibacterial Drug Intermediates Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

目次

This research report focuses on the Quinolone Antibacterial Drug Intermediates Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Quinolone Antibacterial Drug Intermediates Product Introduction
  • 1.2 Global Quinolone Antibacterial Drug Intermediates Market Size Forecast
    • 1.2.1 Global Quinolone Antibacterial Drug Intermediates Sales Value (2020-2031)
    • 1.2.2 Global Quinolone Antibacterial Drug Intermediates Sales Volume (2020-2031)
    • 1.2.3 Global Quinolone Antibacterial Drug Intermediates Sales Price (2020-2031)
  • 1.3 Quinolone Antibacterial Drug Intermediates Market Trends & Drivers
    • 1.3.1 Quinolone Antibacterial Drug Intermediates Industry Trends
    • 1.3.2 Quinolone Antibacterial Drug Intermediates Market Drivers & Opportunity
    • 1.3.3 Quinolone Antibacterial Drug Intermediates Market Challenges
    • 1.3.4 Quinolone Antibacterial Drug Intermediates Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Quinolone Antibacterial Drug Intermediates Players Revenue Ranking (2024)
  • 2.2 Global Quinolone Antibacterial Drug Intermediates Revenue by Company (2020-2025)
  • 2.3 Global Quinolone Antibacterial Drug Intermediates Players Sales Volume Ranking (2024)
  • 2.4 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Company Players (2020-2025)
  • 2.5 Global Quinolone Antibacterial Drug Intermediates Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Quinolone Antibacterial Drug Intermediates Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Quinolone Antibacterial Drug Intermediates Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Quinolone Antibacterial Drug Intermediates
  • 2.9 Quinolone Antibacterial Drug Intermediates Market Competitive Analysis
    • 2.9.1 Quinolone Antibacterial Drug Intermediates Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Quinolone Antibacterial Drug Intermediates Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quinolone Antibacterial Drug Intermediates as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Levofloxacin Carboxylic Acid
    • 3.1.2 Fluoroquinolonic Acid
    • 3.1.3 Tetrafluorophthalic Acid
    • 3.1.4 Others
  • 3.2 Global Quinolone Antibacterial Drug Intermediates Sales Value by Type
    • 3.2.1 Global Quinolone Antibacterial Drug Intermediates Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Quinolone Antibacterial Drug Intermediates Sales Value, by Type (2020-2031)
    • 3.2.3 Global Quinolone Antibacterial Drug Intermediates Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type
    • 3.3.1 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Quinolone Antibacterial Drug Intermediates Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Quinolone Antibacterial Drug Intermediates Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Quinolone Antibacterial Drug Intermediates Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Ofloxacin
    • 4.1.2 Moxifloxacin
    • 4.1.3 Ciprofloxacin
    • 4.1.4 Others
  • 4.2 Global Quinolone Antibacterial Drug Intermediates Sales Value by Application
    • 4.2.1 Global Quinolone Antibacterial Drug Intermediates Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Quinolone Antibacterial Drug Intermediates Sales Value, by Application (2020-2031)
    • 4.2.3 Global Quinolone Antibacterial Drug Intermediates Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application
    • 4.3.1 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Quinolone Antibacterial Drug Intermediates Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Quinolone Antibacterial Drug Intermediates Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Quinolone Antibacterial Drug Intermediates Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Quinolone Antibacterial Drug Intermediates Sales Value by Region
    • 5.1.1 Global Quinolone Antibacterial Drug Intermediates Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2020-2025)
    • 5.1.3 Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (2026-2031)
    • 5.1.4 Global Quinolone Antibacterial Drug Intermediates Sales Value by Region (%), (2020-2031)
  • 5.2 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region
    • 5.2.1 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2020-2025)
    • 5.2.3 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (2026-2031)
    • 5.2.4 Global Quinolone Antibacterial Drug Intermediates Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Quinolone Antibacterial Drug Intermediates Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 5.4.2 North America Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 5.5.2 Europe Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Quinolone Antibacterial Drug Intermediates Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 5.7.2 South America Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Quinolone Antibacterial Drug Intermediates Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Quinolone Antibacterial Drug Intermediates Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.3.2 United States Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.4.2 Europe Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.5.2 China Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.6.2 Japan Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.7.2 South Korea Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Quinolone Antibacterial Drug Intermediates Sales Value, 2020-2031
    • 6.9.2 India Quinolone Antibacterial Drug Intermediates Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Quinolone Antibacterial Drug Intermediates Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Anant Pharmaceuticals
    • 7.1.1 Anant Pharmaceuticals Company Information
    • 7.1.2 Anant Pharmaceuticals Introduction and Business Overview
    • 7.1.3 Anant Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Anant Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.1.5 Anant Pharmaceuticals Recent Development
  • 7.2 Veeprho Pharmaceuticals
    • 7.2.1 Veeprho Pharmaceuticals Company Information
    • 7.2.2 Veeprho Pharmaceuticals Introduction and Business Overview
    • 7.2.3 Veeprho Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Veeprho Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.2.5 Veeprho Pharmaceuticals Recent Development
  • 7.3 Anax Laboratories
    • 7.3.1 Anax Laboratories Company Information
    • 7.3.2 Anax Laboratories Introduction and Business Overview
    • 7.3.3 Anax Laboratories Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Anax Laboratories Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.3.5 Anax Laboratories Recent Development
  • 7.4 Santa Cruz Biotechnology
    • 7.4.1 Santa Cruz Biotechnology Company Information
    • 7.4.2 Santa Cruz Biotechnology Introduction and Business Overview
    • 7.4.3 Santa Cruz Biotechnology Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Santa Cruz Biotechnology Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.4.5 Santa Cruz Biotechnology Recent Development
  • 7.5 Chemicea Pharmaceuticals
    • 7.5.1 Chemicea Pharmaceuticals Company Information
    • 7.5.2 Chemicea Pharmaceuticals Introduction and Business Overview
    • 7.5.3 Chemicea Pharmaceuticals Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Chemicea Pharmaceuticals Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.5.5 Chemicea Pharmaceuticals Recent Development
  • 7.6 Zhejiang Starry Pharmaceutical
    • 7.6.1 Zhejiang Starry Pharmaceutical Company Information
    • 7.6.2 Zhejiang Starry Pharmaceutical Introduction and Business Overview
    • 7.6.3 Zhejiang Starry Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Zhejiang Starry Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.6.5 Zhejiang Starry Pharmaceutical Recent Development
  • 7.7 Jiangxi Chibang Pharmaceutical
    • 7.7.1 Jiangxi Chibang Pharmaceutical Company Information
    • 7.7.2 Jiangxi Chibang Pharmaceutical Introduction and Business Overview
    • 7.7.3 Jiangxi Chibang Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Jiangxi Chibang Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.7.5 Jiangxi Chibang Pharmaceutical Recent Development
  • 7.8 Inner Mongania Yuanhong Fine Chemical
    • 7.8.1 Inner Mongania Yuanhong Fine Chemical Company Information
    • 7.8.2 Inner Mongania Yuanhong Fine Chemical Introduction and Business Overview
    • 7.8.3 Inner Mongania Yuanhong Fine Chemical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Inner Mongania Yuanhong Fine Chemical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.8.5 Inner Mongania Yuanhong Fine Chemical Recent Development
  • 7.9 Jiangxi Chenyang Pharmaceutical
    • 7.9.1 Jiangxi Chenyang Pharmaceutical Company Information
    • 7.9.2 Jiangxi Chenyang Pharmaceutical Introduction and Business Overview
    • 7.9.3 Jiangxi Chenyang Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Jiangxi Chenyang Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.9.5 Jiangxi Chenyang Pharmaceutical Recent Development
  • 7.10 Jiangxi Dadi Pharm
    • 7.10.1 Jiangxi Dadi Pharm Company Information
    • 7.10.2 Jiangxi Dadi Pharm Introduction and Business Overview
    • 7.10.3 Jiangxi Dadi Pharm Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Jiangxi Dadi Pharm Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.10.5 Jiangxi Dadi Pharm Recent Development
  • 7.11 Shanghai Nuvit Bio-Tech
    • 7.11.1 Shanghai Nuvit Bio-Tech Company Information
    • 7.11.2 Shanghai Nuvit Bio-Tech Introduction and Business Overview
    • 7.11.3 Shanghai Nuvit Bio-Tech Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Shanghai Nuvit Bio-Tech Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.11.5 Shanghai Nuvit Bio-Tech Recent Development
  • 7.12 Biocompounds Pharmaceutical
    • 7.12.1 Biocompounds Pharmaceutical Company Information
    • 7.12.2 Biocompounds Pharmaceutical Introduction and Business Overview
    • 7.12.3 Biocompounds Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Biocompounds Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.12.5 Biocompounds Pharmaceutical Recent Development
  • 7.13 Guobang Pharma
    • 7.13.1 Guobang Pharma Company Information
    • 7.13.2 Guobang Pharma Introduction and Business Overview
    • 7.13.3 Guobang Pharma Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Guobang Pharma Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.13.5 Guobang Pharma Recent Development
  • 7.14 Binhai Golden Hilen
    • 7.14.1 Binhai Golden Hilen Company Information
    • 7.14.2 Binhai Golden Hilen Introduction and Business Overview
    • 7.14.3 Binhai Golden Hilen Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Binhai Golden Hilen Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.14.5 Binhai Golden Hilen Recent Development
  • 7.15 Zhejiang Langhua Pharmaceutical
    • 7.15.1 Zhejiang Langhua Pharmaceutical Company Information
    • 7.15.2 Zhejiang Langhua Pharmaceutical Introduction and Business Overview
    • 7.15.3 Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.15.5 Zhejiang Langhua Pharmaceutical Recent Development
  • 7.16 Zhejiang Jingxin Pharmaceutical
    • 7.16.1 Zhejiang Jingxin Pharmaceutical Company Information
    • 7.16.2 Zhejiang Jingxin Pharmaceutical Introduction and Business Overview
    • 7.16.3 Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug Intermediates Product Offerings
    • 7.16.5 Zhejiang Jingxin Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Quinolone Antibacterial Drug Intermediates Industrial Chain
  • 8.2 Quinolone Antibacterial Drug Intermediates Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Quinolone Antibacterial Drug Intermediates Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Quinolone Antibacterial Drug Intermediates Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer